We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.37B
1-Year Est. Return 28.86%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+28.86%
3 Year Est. Return
+82.88%
5 Year Est. Return
+98.91%
10 Year Est. Return
+378.43%
AUM
$2.19B
AUM Growth
+$17.4M
Cap. Flow
-$35.3M
Cap. Flow %
-1.61%
Top 10 Hldgs %
33.01%
Holding
1,187
New
68
Increased
215
Reduced
391
Closed
233

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$13.3M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.44M
3
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$6.01M
4
LLY icon
Eli Lilly
LLY
+$5.65M
5
DAN icon
Dana Inc
DAN
+$4.56M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$7.59M
2
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$4.41M
3
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$4.18M
4
UBER icon
Uber
UBER
+$4.09M
5
META icon
Meta Platforms (Facebook)
META
+$3.98M

Sector Composition

Rank Sector Weight
1 Technology 16.36%
2 Financials 9.22%
3 Consumer Discretionary 7.5%
4 Healthcare 7.23%
5 Industrials 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLB icon
1001
Columbia Banking Systems
COLB
$8.82B
– –
-51
Closed -$1.31K
COO icon
1002
Cooper Companies
COO
$14.4B
– –
-29
Closed -$1.99K
CORZ icon
1003
Core Scientific
CORZ
$6.81B
– –
-68
Closed -$1.22K
CPK icon
1004
Chesapeake Utilities
CPK
$3.17B
– –
-7
Closed -$948
CPRX
1005
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-18
Closed -$355
CRDO icon
1006
Credo Technology Group
CRDO
$45.7B
– –
-8
Closed -$1.17K
CRL icon
1007
Charles River Laboratories
CRL
$12.5B
– –
-12
Closed -$1.88K
CRNX icon
1008
Crinetics Pharmaceuticals
CRNX
$8.9B
– –
-21
Closed -$875
CRTO icon
1009
Criteo S.A. Ordinary Shares
CRTO
$913M
– –
-12
Closed -$272
CSW
1010
CSW Industrials
CSW
$5.71B
– –
-4
Closed -$971
CTSH icon
1011
Cognizant
CTSH
$26B
– –
-38
Closed -$2.55K
CUBE icon
1012
CubeSmart
CUBE
$9.4B
– –
-663
Closed -$27K
CUK
1013
DELISTED
Carnival PLC
CUK
– –
-17
Closed -$450
CWAN
1014
DELISTED
Clearwater Analytics
CWAN
– –
-61
Closed -$1.1K
CYTK icon
1015
Cytokinetics
CYTK
$10.5B
– –
-6
Closed -$330
DB icon
1016
Deutsche Bank
DB
$71.4B
– –
-47
Closed -$1.67K
DG icon
1017
Dollar General
DG
$28B
– –
-90
Closed -$9.3K
DNTH icon
1018
Dianthus Therapeutics
DNTH
$6.05B
– –
-9
Closed -$355
DT icon
1019
Dynatrace
DT
$14.2B
– –
-63
Closed -$3.05K
DTE icon
1020
DTE Energy
DTE
$29.2B
– –
-42
Closed -$6.05K
DVN icon
1021
Devon Energy
DVN
$47.4B
– –
-168
Closed -$5.89K
DXCM icon
1022
DexCom
DXCM
$31.8B
– –
-42
Closed -$2.83K
EPAC icon
1023
Enerpac Tool Group
EPAC
$1.92B
– –
-17
Closed -$697
EQNR icon
1024
Equinor
EQNR
$93.1B
– –
-26
Closed -$634
ERIC icon
1025
Ericsson
ERIC
$33.3B
– –
-85
Closed -$716
39 40
41
42 43

Similar funds

SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
RG
Renaissance Group Covington, Kentucky $2.39B AUM 27.81% 1-Year Est. Return
MAS
Meeder Advisory Services Dublin, Ohio $2.39B AUM 23.78% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Montag & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Montag & Associates held 1,187 positions worth $2.19B, up 0.8% from $2.17B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Montag & Associates's Q4 2025 filing shows 68 new, 215 increased, 391 reduced and 233 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 56,147 shares worth $6.85M. The largest sale was Fiserv Inc, an estimated $7.59M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Montag & Associates's largest Q4 2025 buy was State Street SPDR S&P Biotech ETF: 56,147 shares worth $6.85M.
  • Montag & Associates added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $13.3M increase.
  • Montag & Associates's biggest Q4 2025 reduction was Fiserv Inc, cutting an estimated $7.59M.
  • Montag & Associates fully exited iShares MSCI Germany ETF in Q4 2025, selling an estimated $2.49M.
  • Montag & Associates's ten largest holdings make up 33% of its $2.19B portfolio in Q4 2025.
  • Montag & Associates opened 68 new positions and closed 233 in Q4 2025.
  • Montag & Associates's portfolio value rose 0.8% quarter-over-quarter to $2.19B.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.